Page last updated: 2024-09-05

l 778,123 and Lung Neoplasms

l 778,123 has been researched along with Lung Neoplasms in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hamilton, AD; Kastens, E; Lantry, LE; Liu, G; Lubet, RA; Sebti, SM; Wang, Y; You, M; Zhang, Z	1
Heymach, JV; Johnson, BE	1
Bernhard, EJ; DeLaney, TF; Deutsch, P; Hahn, SM; Haller, DG; Kiel, KD; McKenna, WG; Mohiuddin, M; Morrison, B; Muschel, RJ; Pramanik, B; Regine, W; Smith, D; Stevenson, JP; Tepper, J	1

Reviews

1 review(s) available for l 778,123 and Lung Neoplasms

Article	Year
Farnesyl transferase inhibitors for patients with lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Jun-15, Volume: 10, Issue:12 Pt 2 Topics: Alkyl and Aryl Transferases; Apoptosis; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Clinical Trials as Topic; Farnesyltranstransferase; Humans; Imidazoles; Lung Neoplasms; Quinolones; Signal Transduction; Treatment Outcome	2004

Article

Year

Farnesyl transferase inhibitors for patients with lung cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Jun-15, Volume: 10, Issue:12 Pt 2

Topics: Alkyl and Aryl Transferases; Apoptosis; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Clinical Trials as Topic; Farnesyltranstransferase; Humans; Imidazoles; Lung Neoplasms; Quinolones; Signal Transduction; Treatment Outcome

2004

Trials

1 trial(s) available for l 778,123 and Lung Neoplasms

Article	Year
A Phase I trial of the farnesyltransferase inhibitor L-778,123 and radiotherapy for locally advanced lung and head and neck cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 2002, Volume: 8, Issue:5 Topics: Adult; Aged; Alkyl and Aryl Transferases; Carcinoma, Non-Small-Cell Lung; Cell Survival; Combined Modality Therapy; Dose-Response Relationship, Radiation; Farnesyltranstransferase; Female; Head and Neck Neoplasms; Hematologic Diseases; Humans; Imidazoles; Lung Neoplasms; Male; Middle Aged; Mouth Mucosa; Nausea; Skin Diseases; Stomatitis; Treatment Outcome; Tumor Cells, Cultured; Vomiting	2002

Article

Year

A Phase I trial of the farnesyltransferase inhibitor L-778,123 and radiotherapy for locally advanced lung and head and neck cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2002, Volume: 8, Issue:5

Topics: Adult; Aged; Alkyl and Aryl Transferases; Carcinoma, Non-Small-Cell Lung; Cell Survival; Combined Modality Therapy; Dose-Response Relationship, Radiation; Farnesyltranstransferase; Female; Head and Neck Neoplasms; Hematologic Diseases; Humans; Imidazoles; Lung Neoplasms; Male; Middle Aged; Mouth Mucosa; Nausea; Skin Diseases; Stomatitis; Treatment Outcome; Tumor Cells, Cultured; Vomiting

2002

Other Studies

1 other study(ies) available for l 778,123 and Lung Neoplasms

Article	Year
Farnesyltransferase inhibitors are potent lung cancer chemopreventive agents in A/J mice with a dominant-negative p53 and/or heterozygous deletion of Ink4a/Arf. Oncogene, 2003, Sep-18, Volume: 22, Issue:40 Topics: Adenocarcinoma; Alkyl and Aryl Transferases; Animals; Anticarcinogenic Agents; Cyclin-Dependent Kinase Inhibitor p16; Enzyme Inhibitors; Farnesyltranstransferase; Gene Deletion; Genes, Dominant; Genes, p53; Heterozygote; Imidazoles; Lung Neoplasms; Methionine; Mice; Mice, Inbred A; Mice, Knockout; Mice, Transgenic	2003

Article

Year

Farnesyltransferase inhibitors are potent lung cancer chemopreventive agents in A/J mice with a dominant-negative p53 and/or heterozygous deletion of Ink4a/Arf.

Oncogene, 2003, Sep-18, Volume: 22, Issue:40

Topics: Adenocarcinoma; Alkyl and Aryl Transferases; Animals; Anticarcinogenic Agents; Cyclin-Dependent Kinase Inhibitor p16; Enzyme Inhibitors; Farnesyltranstransferase; Gene Deletion; Genes, Dominant; Genes, p53; Heterozygote; Imidazoles; Lung Neoplasms; Methionine; Mice; Mice, Inbred A; Mice, Knockout; Mice, Transgenic

2003